Participants were randomly assigned to three groups receiving : ( 1 ) Folate-1 : 1 mg/day folate supplements ( n = 27 ) ; ( 2 ) Folate-5 : 5 mg/day folate supplements ( n = 27 ) , and ( 3 ) placebo ( n = 27 ) for 8 weeks .